DOPATREE
Preview
Open in TheBrain
DOPATREE
UNITED STATES GOVERNMENT ORGANIZATIONS / LISTINGS
US FOOD AND DRUG ADMINISTRATION (FDA)
DRUGS AND BIOLOGICS / RELATED / US
DRUG SAFETY AND BIOLOGIC SAFETY (PHARMACOVIGILANCE, PV, CLINICAL, POSTMARKETING, SERIOUS ADVERSE EVENT, SAE, IND, 7-DAY, 15-DAY, EXPEDITED, SIDE EFFECTS, ICSR, PSUR, LITERATURE, SURVEILLANCE, E2B, SAFETY REPORTING, DATA, MEDICATION)
DRUG SAFETY AND BIOLOGIC SAFETY / RELATED / INTL
TREATMENT-RELATED CONDITIONS-ALL (DRUG-RELATED, BIOLOGIC-RELATED, DEVICE-RELATED, TREATMENT EMERGENT ADVERSE EVENTS, TEAE, ADVERSE DRUG REACTIONS, SIDE EFFECTS, ALL TOXICITIES, TOXICITY, PRODUCT-RELATED, DRUG-INDUCED)
TREATMENT-RELATED CONDITIONS / LISTINGS
BLEEDING DISORDERS-ALL (COAGULAPATHY, HERITABLE BLEEDING DISORDERS, CLOTTING DISORDERS, HEMORRHAGE)
BLEEDING DISORDERS / MITIGATIONS
Parents
BLEEDING DISORDERS-ALL (COAGULAPATHY, HERITABLE BLEEDING DISORDERS, CLOTTING DISORDERS, HEMORRHAGE)
Children
AVOID USE IN PATIENTS WITH ACTIVE BLEEDING
HOLD TREATMENT PRIOR TO ANY PLANNED SURGICAL PROCEDURES
INTERRUPT, REDUCE, OR DISCONTINUE TREATMENT DOSE OR RATE DEPENDING ON SEVERITY
MONITOR PATIENTS FOR SIGNS AND SYMPTOMS